UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (526) 526
science & technology (471) 471
life sciences & biomedicine (468) 468
female (323) 323
male (322) 322
bendamustine hydrochloride (303) 303
aged (300) 300
middle aged (293) 293
bendamustine (278) 278
oncology (276) 276
hematology (273) 273
antineoplastic combined chemotherapy protocols - therapeutic use (272) 272
nitrogen mustard compounds - administration & dosage (195) 195
bendamustine hydrochloride - administration & dosage (188) 188
adult (186) 186
rituximab (171) 171
treatment outcome (161) 161
aged, 80 and over (152) 152
leukemia, lymphocytic, chronic, b-cell - drug therapy (148) 148
antineoplastic agents (135) 135
antineoplastic combined chemotherapy protocols - adverse effects (127) 127
nitrogen mustard compounds - therapeutic use (125) 125
nitrogen mustard compounds - adverse effects (118) 118
rituximab - administration & dosage (113) 113
antimitotic agents (103) 103
chemotherapy (102) 102
cancer (97) 97
care and treatment (95) 95
antineoplastic combined chemotherapy protocols - administration & dosage (92) 92
lymphomas (86) 86
biological and medical sciences (81) 81
medical sciences (81) 81
antineoplastic agents - therapeutic use (80) 80
antibodies, monoclonal, murine-derived - administration & dosage (79) 79
recurrence (79) 79
lymphoma (78) 78
disease-free survival (77) 77
medicine & public health (74) 74
bendamustine hydrochloride - adverse effects (72) 72
retrospective studies (67) 67
antineoplastic agents, alkylating - therapeutic use (65) 65
chronic lymphocytic leukemia (65) 65
drug administration schedule (64) 64
lymphoma, non-hodgkin - drug therapy (64) 64
pharmacology & pharmacy (63) 63
lymphoma, mantle-cell - drug therapy (60) 60
bendamustine hydrochloride - therapeutic use (56) 56
hematologic and hematopoietic diseases (56) 56
multiple myeloma - drug therapy (56) 56
antineoplastic agents - administration & dosage (55) 55
cyclophosphamide - administration & dosage (55) 55
drug therapy (55) 55
leukemia (55) 55
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (55) 55
remission induction (55) 55
analysis (54) 54
prognosis (50) 50
antineoplastic agents - adverse effects (49) 49
neoplasm staging (49) 49
survival rate (49) 49
clinical trials (48) 48
antineoplastic agents, alkylating - administration & dosage (47) 47
multiple myeloma (47) 47
antineoplastic agents, alkylating - adverse effects (45) 45
follow-up studies (44) 44
pharmacology. drug treatments (43) 43
hemic and lymphatic diseases (41) 41
animals (40) 40
hematology, oncology and palliative medicine (40) 40
lymphoma, b-cell - drug therapy (40) 40
lymphoma, follicular - drug therapy (40) 40
drug resistance, neoplasm (39) 39
tumors (39) 39
mantle cell lymphoma (37) 37
neoplasm recurrence, local - drug therapy (37) 37
patients (37) 37
salvage therapy (37) 37
vidarabine - analogs & derivatives (37) 37
leukemia, lymphocytic, chronic, b-cell - pathology (36) 36
relapse (36) 36
toxicity (36) 36
dexamethasone - administration & dosage (35) 35
dosage and administration (35) 35
prednisone - administration & dosage (35) 35
bortezomib (34) 34
leukemia, lymphocytic, chronic, b-cell - mortality (34) 34
survival analysis (34) 34
research (33) 33
vidarabine - administration & dosage (32) 32
non-hodgkin's lymphomas (31) 31
rituximab - adverse effects (31) 31
antibodies, monoclonal, murine-derived - adverse effects (30) 30
dose-response relationship, drug (30) 30
thalidomide - analogs & derivatives (30) 30
young adult (30) 30
antibodies, monoclonal - administration & dosage (29) 29
doxorubicin - administration & dosage (29) 29
nitrogen mustard compounds - pharmacokinetics (29) 29
vincristine - administration & dosage (29) 29
abridged index medicus (27) 27
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (554) 554
Japanese (13) 13
German (11) 11
Russian (3) 3
Spanish (2) 2
Chinese (1) 1
Czech (1) 1
French (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2018, Volume 378, Issue 12, pp. 1107 - 1120
Journal Article
Journal Article
Journal Article
Annals of oncology, ISSN 0923-7534, 09/2018, Volume 29, Issue 9, pp. 1932 - 1938
relapsed/refractory NHL | phase Ib | venetoclax | bendamustine-rituximab | Salvage Therapy - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Rituximab - pharmacokinetics | Bendamustine Hydrochloride - adverse effects | Chemotherapy-Induced Febrile Neutropenia - etiology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Bendamustine Hydrochloride - pharmacokinetics | Lymphoma, Non-Hodgkin - pathology | Neoplasm Recurrence, Local - pathology | Bendamustine Hydrochloride - administration & dosage | Bridged Bicyclo Compounds, Heterocyclic - adverse effects | Aged, 80 and over | Adult | Female | Lymphoma, Non-Hodgkin - drug therapy | Rituximab - adverse effects | Chemotherapy-Induced Febrile Neutropenia - epidemiology | Drug Administration Schedule | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Disease Progression | Sulfonamides - pharmacokinetics | Rituximab - administration & dosage | Maximum Tolerated Dose | Progression-Free Survival | Sulfonamides - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Salvage Therapy - methods | Sulfonamides - administration & dosage | Bridged Bicyclo Compounds, Heterocyclic - pharmacokinetics | Drug Resistance, Neoplasm - drug effects | Index Medicus | relapsed | refractory NHL | Original | bendamustine–rituximab
Journal Article
Journal Article
The Lancet. Haematology, ISSN 2352-3026, 2016, Volume 4, Issue 1, pp. e15 - e23
Journal Article
The lancet oncology, ISSN 1470-2045, 09/2018, Volume 19, Issue 9, pp. 1215 - 1228
Journal Article